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ABSTRACT
Eastern Europe (EE) has been severely aﬀected by mosquito-borne viruses (moboviruses). In
this review, we summarize the epidemiology of moboviruses, with particular attention to
West Nile virus (WNV). The study of WNV human cases in EE between 2010 and 2016, revealed
that the epidemiology of WNV in EE is complex with the combination of introduction of
diﬀerent WNV strains from lineages 1 and 2, and the establishment of endemic cycles. We
found a positive correlation between the risk of WNV re-emergence in an area and the
number of human cases reported in the previous year. We also report the main ecological
and biological characteristics of the key mosquito species vectors of moboviruses. Recent
expansion of invasive mosquito species in EE, mainly Aedes albopictus but also Aedes
aegypti and Culex quinquefasciatus, may result in new scenarios with an increased risk of
transmission of moboviruses. Main gaps of knowledge in relation to moboviruses and their
vectors in EE are identiﬁed. Understanding the epidemiology of moboviruses in EE is essential
for the improvement of their surveillance and the control of the diseases they cause.
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Introduction
Arthropod-borne viruses (arboviruses) are a group of
viruses that are transmitted by arthropod vectors and
cause disease in humans and animals. Therefore, disease
occurrence relies on the presence of the virus, suscep-
tible hosts and competent vectors. Diseases caused by
arboviruses have been reported for centuries, but in the
recent years, the notiﬁcation of outbreaks of arboviral
diseases has dramatically increased [1]. Human popula-
tion growth, deforestation, urbanization, movement of
people, animals and vectors have contributed to disse-
mination of arboviruses. The impact of climate change
on vector-borne diseases is controversial since it can
inﬂuence arthropod vectors abundance and virus trans-
mission in diﬀerent ways. In fact, the eﬀects of the
climate are considered species-speciﬁc and location-
speciﬁc [2]. Some arboviruses that had been neglected
for a long time, have emerged in the last decades as
important health threats, for example Zika virus (ZIKV) in
South and Central America [3], Yellow fever virus (YFV)
in Brazil [4] and West Nile virus (WNV) lineage 2 in
Southern and Eastern Europe [5]. Nowadays arboviruses
have a worldwide distribution, being present in all con-
tinents except Antarctica. However, each arbovirus will
generally have a focal distribution because of its speciﬁc
requirements in relation to vertebrate hosts, vectors and
ecological factors needed to maintain its transmission
cycle [1].
Arboviruses that are transmitted to vertebrates via
competent hematophagous mosquitoes (Diptera:
Culicidae) are called mosquito-borne viruses (mobo-
viruses). Competent mosquitoes are those capable of
ﬁrst acquiring the virus through feeding on a viraemic
host, then replicate the virus and ﬁnally deliver it to a
new host through the saliva in the next blood feed-
ing. Vertical transmission, i.e. the transmission of a
pathogen from a parent to its progeny, represents
another mechanism for arbovirus transmission and
ampliﬁcation in nature. Additionally, the mechanisms
by which most arboviruses are trans-seasonally main-
tained (i.e. overwintering) remain unclear, and vertical
transmission oﬀers a likely explanation for the persis-
tence of arboviruses during period of adverse envir-
onmental conditions.
Moboviruses aﬀecting humans are concentrated
in four families: Flaviviridae (genus Flavivirus),
Togaviridae (genus Alphavirus), Peribunyaviridae
(genus Orthobunyavirus) and Phenuiviridae (genus
Phlebovirus). The virus species names included in
the present review have been updated following
the International Committee on Taxonomy of
Viruses (ICTV). The present review brieﬂy summarizes
the group of moboviruses present in Eastern Europe
(EE) (Figure 1). For more details on virus species
see for example [1,6–8]. In the case of WNV, being
the main mobovirus present in EE, we have focused
on its distribution and spread in recent years using
data on the human cases provided by the European
Centre for Disease Prevention and Control (ECDC).
Finally, the review also gives an overview of the
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main biological and ecological characteristics of the
mosquito species involved in moboviruses transmis-
sion in EE. As there is not a clear classiﬁcation of
the countries included within EE, we based our
choice on commonly accepted geographical criteria.
Accordingly, we included Albania, Belarus, Bulgaria,
Greece, Kosovo, the Former Yugoslav Republic of
Macedonia (from here onwards, Macedonia),
Moldova, Montenegro, Romania, Russia, Serbia,
Turkey and Ukraine as belonging to EE.
Mosquito-borne viruses circulating in EE
The distribution of the diﬀerent moboviruses in the EE
countries included in the study is shown in Figure 1.
Flaviviruses (Genus Flavivirus, Family
Flaviviridae)
West nile virus (WNV)
Before 2004. WNV has been responsible for repeated
disease outbreaks in both horses and humans in Europe
for more than 50 years [5]. Most of those outbreaks
were caused by lineage 1 strains of the European
Mediterranean/Kenyan cluster characterized by a mod-
erate pathogenicity for horses and humans, and limited
or no pathogenicity for birds [9]. However, in 1996 the
ﬁrst major West Nile fever (WNF) epidemic in humans in
Europe occurred in Romania, and was caused by WNV
lineage 1 strain of the Israeli/American cluster, consid-
ered as highly pathogenic for horses, humans and
birds [10]. It occurred in south-eastern Romania, in the
Danube valley and Bucharest, causing 352 neurological
cases with 17 deaths in humans [9,11]. Culex pipienswas
probably the main mosquito species involved in the
epidemic [11]. Twelve further cases of WNV infection
occurred in Bucharest and the lower Danube delta in
1997, and one more in Bucharest in 1998, which
were indicative of persistent WNV transmission in
south-eastern Romania [12]. Lineage 1 strain was
reported to have continued circulating in Romania
after 1996, up to 2009 [13].
In 1999, 84 cases of meningoencephalitis, 40 of
which were fatal, occurred in Volgograd Region
(Russia). The strain had a high degree of similarity to
the strain isolated in Romania (Bucharest region) in
1996, and to that isolated in New York in 1999 [14].
Between 2000 and 2003 WNV lineage 1 circulated in
Volgograd and Astrakhan regions [15].
Between 2004 and 2010. Before 2004, all WNV
outbreaks in Europe had been caused by lineage 1,
until a case of encephalitis in a wild goshawk
(Accipiter gentilis) in Hungary resulted in the isolation
of WNV lineage 2 [16]. Lineage 2 strains were
thought to be restricted to sub Saharan Africa and
were considered as low pathogenic [9]. Between
2004 and 2007 only sporadic cases of WNV lineage
2 in birds of prey and mammals were detected in
Figure 1. Distribution of the diﬀerent moboviruses in the EE countries included in the study: West Nile virus (WNV), Usutu virus
(USUV), Dengue virus (DENV), Bunyamwera orthobunyavirus (BUNV), California encephalitis virus (CEV), Turlock orthobunyavirus
(TURV), Rift Valley fever phlebovirus (RVFV) and Sindbis virus (SINV).
2 S. NAPP ET AL.
Hungary [16]. However, in 2008 the virus expanded
westwards and southwards causing mortality in birds
of prey, neurological disease in horses and humans
in Hungary, and reaching the eastern part of Austria,
where it was detected in dead wild birds [17]. In
2009 further outbreaks were detected in Hungary
and Austria [17,18].
In 2007, RNA of WNV lineage 2 was detected in
brain and blood samples from humans in the
Volgograd region, after which WNF epidemics with
large number of human cases were observed in
Russia [13]. However, retrospectively, WNV lineage 2
was identiﬁed in the sera of two patients from Rostov
region aﬀected by WNF in 2004 [15]. Russian out-
breaks were caused by a WNV lineage 2 strain, but it
belonged to a clade diﬀerent to the cluster where the
Hungarian strain was grouped [19]. Phylogeographic
studies suggest at least two diﬀerent introductions of
WNV lineage 2 from Africa into Europe, one into
Central Europe (Hungary) and the other to Russia
probably linked to diﬀerent bird migration routes [20].
Furthermore, in 2005, WNV lineage 1 reappeared in
Astrakhan region [15].
After 2010. For the period 2010–2016, data on
human cases of WNF occurred in the EE countries
included in our study were obtained from the
European Centre for Disease Prevention and Control
(ECDC) through a request to The European
Surveillance System (TESSy). ECDC WNF cases include
both probable and conﬁrmed cases of WNV infection,
as deﬁned in the Commission Decision 2008/426/EC.
According to that legislation, a probable case refers to
any person meeting the clinical criteria and with
either an epidemiological link or a laboratory test for
a probable case (i.e. presence of WNV speciﬁc anti-
bodies). In contrast, a conﬁrmed case refers to any
person meeting the laboratory criteria for case con-
ﬁrmation (e.g. isolation of WNV or detection of WNV
nucleic acid from blood or cerebrospinal ﬂuid).
According to the ECDC data, 2873 WNV human
cases were reported in those countries within that
period. Russia was the country with the most cases
reported, but Greece, Serbia, and to a lesser extent
Romania were also severely aﬀected by WNV epi-
demics in humans (Table 1). Of the countries included
in our study, only Belarus, Moldova and Montenegro
did not report any case of WNV in humans between
2010 and 2016.
There was also quite a lot of variation among years,
with 2010 and 2012 as the years with the most cases
reported (812 and 675, respectively), mainly due to
the circulation of WNV in Russia, where 519 and 412
cases were reported on those years respectively
(Table 1). In 2013 there were also a signiﬁcant number
of cases reported (590), of which 302 occurred in
Serbia.
Central/Southern-European lineage 2 cluster. In
2010, a major WNF epidemic occurred in the city of
Thessaloniki (Greece) causing 197 neurological cases
in humans with 33 deaths [5]. The analysis of serum
samples collected in 2007 from residents of rural areas
of northern Greece evidenced that WNV (or a closely
antigenically related ﬂavivirus) was already circulating
in that area by that time [21]. WNV reappeared in the
years after the 2010 epidemic, and spread both south
and east of the Thessaloniki area, causing 99 human
cases in 2011, 157 in 2012 and 85 in 2013 (Table 1 &
Figure 2). After only 15 cases in 2014, no further cases
were detected in 2015 and 2016. The complete gen-
ome analysis of the WNV circulating in 2010 showed a
close genetic relationship to the lineage 2 strain that
had emerged in Hungary in 2004 [22]. Phylogenetic
studies carried out between 2011 and 2014 in Greece
showed the similarity to the strains previously isolated
in Greece, and therefore the establishment of an
endemic cycle [23–25].
In 2011, WNV spread to Albania and Macedonia
where it caused 2 and 4 human cases, respectively,
and in 2012 it also reached Kosovo causing 4 further
human cases (Table 1 and Figure 2). Although there is
no information on the strain involved, given the proxi-
mity, the spread of the strain that was aﬀecting
Greece seems the most likely explanation.
In 2012, 68 human cases were reported in Serbia, 50
of which were detected in City of Belgrade district
(Figure 2). In 2013, WNV re-emerged causing 302
human cases, the majority of which occurred in City of
Belgrade (171 cases) but also surrounding districts
(Figure 2). In the following years, the number of cases
decreased (76 in 2014, 28 in 2015, and 41 in 2016) but
the areas aﬀected remained the same. Phylogenetic
analyses of Serbian isolates from 2012 evidenced their
close relation to Hungarian and Greek isolates [26].
In 2012 two human cases of WNF were detected in
Bulgaria, where there had been two cases reported
in horses in 2010 (Figure 2). There was no further detec-
tion until 2015 when 3 human cases were reported.
Phylogenetic analysis showed that the virus was closely
related to theWNV lineage 2 strain isolated inGreece [27].
Table 1. Number of human cases of WNV reported between
2010 and 2016 in the EE countries under study
Country 2010 2011 2012 2013 2014 2015 2016 Total
Albania 2 2
Belarus
Bulgaria 2 3 1 6
Greece 189 99 157 85 15 545
Kosovo 4 4
Macedonia 4 6 1 11
Moldova
Montenegro
Romania 57 11 14 24 23 32 93 254
Russia 519 153 412 177 29 39 135 1464
Serbia 68 302 76 28 41 515
Turkey 47 3 50
Ukraine 8 12 1 1 22
Total 812 280 675 590 143 102 271 2873
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In 2014, also WNV lineage 2, similar to the Greek
isolate, was detected in the brain of a horse with
severe clinical signs in Bursa region in eastern
Turkey [28], but so far no human cases have been
reported.
Russian/Romanian lineage 2 cluster. In 2010, 519
human cases were reported in Russia, 413 of which
were in the Volgograd region (blue area in Figure 2)
and 59 in the Rostov area (green area in Figure 2). The
strain was the same responsible for the cases between
2004 and 2007 [15]. In 2011, only 153 cases were
reported, mainly in the same areas aﬀected in 2010
(Figure 2). In 2012 cases increased to 412, 210 of
which were in the Volgograd region (blue area in
Figure 2) and 60 to its south in the Astrakhan region
(grey area in Figure 2). In 2013, 177 cases were
Figure 2. Cases of human WNV-infections registered by the ECDC in the countries under study for each year between 2010 and
2016. Distribution of cases is only an approximation as the location is randomly generated within the minimum geographical
unit available in the ECDC data (NUTS3 level or equivalent unit for non-EU countries). Oﬃcial outbreaks in horses reported
through the EU Animal Disease Notiﬁcation System (ADNS) and collected to the RASVE system of the Spanish Ministry of
Agriculture, Fisheries, Food and Environment are also represented.
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registered the majority of which occurred in the
Volgograd and Astrakhan regions. In 2014 and 2015,
only 29 and 39 cases were reported respectively.
However, in 2016, cases increased to 135, with
Saratov region, to the north of Volgograd, as the
most severely aﬀected region with 87 cases (red
area in Figure 2). Considering the pattern of Russian
WNV outbreaks since 2010 (Figure 2), in which WNV
tended to reappear in the previously-aﬀected regions,
with occasional expansion to neighbouring regions,
outbreaks from 2011 onwards are likely be the result
of the establishment of an endemic cycle.
WNV lineage 2 was also detected in Romania in
2010 resulting in 57 human cases, with the peculiarity
that cases were distributed throughout most of the
territory (Figure 2), contrary to what occurs in most
countries where disease is usually clustered in some
areas. Between 2011 and 2015, there were few cases
(between 11 and 32) every year (Table 1), distributed
in diﬀerent regions (Figure 2). In 2016, the number of
cases increased to 93 with some clustering of disease
in the eastern part of the country. Molecular investi-
gations revealed that the viruses involved in cases of
2010 and later years (2011–2013) were related to the
Volgograd 2007 strain [29–31]. Similar to what seems
to have happened in Russia; cases between 2014 and
2016 are likely to have been caused by the overwin-
tering of the strain that was detected in Romania in
previous years.
In Ukraine WNV emerged in 2011 with 8 human
cases distributed in diﬀerent areas south and east in
the country, and further cases were detected in 2012
(12) and 2013 (1), although in areas diﬀerent to those
aﬀected in 2011 (Figure 2). The location of Ukraine
between Russia and Romania, lead us to think that the
virus involved might belong to WNV Russian/
Romanian lineage 2 cluster.
Lineage 1 Central African cluster. Between July and
November 2010, 47 human cases of WNV infection
were identiﬁed in Turkey, mainly in the western part
of the country (Figure 2). In 2011, 3 further cases were
identiﬁed in the same areas, which may be indicative
of endemicity [32] (Figure 2). Sequencing of WNV
from Turkey indicated close relationships to WNV
lineage 1 strain ArB310/67 from the Central African
Republic, and distinct from other WNV circulating in
the Mediterranean Basin, EE, and the Middle East [33].
These ﬁndings suggest independent introductions of
WNV strains from Africa.
Overwintering and seasonality of cases of WNV
in EE. Countries aﬀected by WNV in a given year
normally had repeated cases in the following year,
and generally cases reappeared in those regions that
had been aﬀected in the previous year. We evaluated
the probability of WNV reoccurrence in a given area as
a function of the cases occurred in the previous year.
The results evidence that the higher the number of
cases in a region in a year, the more likely WNV
reappeared in that region in the following year
(Table 2). In fact, 100% of the occasions in which a
region had more than 15 human cases in a year, it was
aﬀected in the following year. If it had between 10
and 15 cases in a year, the probability of recurrence in
the following year was 73%, which decreased to 40%
if it had between 4 and 9 human cases. In contrast,
only 16% of the times a region had less than 4 human
cases in a year it was aﬀected in the following year.
Therefore, the number of human cases in an area in a
given year seems to be positively correlated with
the risk of WNV re-emergence in that area in the
following year.
The evaluation of the seasonality of WNV transmis-
sion in EE indicates that usually cases started to be
reported between beginnings to mid-July, although in
some occasions ﬁrst cases were reported as early as
the end of May or as late as the end of August
(Figure 3). Transmission usually continued through
August, September, and in some cases until October
and even later. However, the period of WNV transmis-
sion in Figure 3 is probably an underestimation as
only the ﬁrst case in each area is available in the
ECDC data, so the actual date of the last case may
be later than reported in the Figure 3.
The relatively short duration of the WNV transmis-
sion season evidences that overwintering, whatever
the mechanism, needs to allow the virus to survive
many months in the absence of transmission by vec-
tors. WNV infection in some bird species seems to
result in the persistence of the virus in some tissues
(even several months) after the initial infection [34].
Experimental infections in diﬀerent bird species
demonstrated that birds may become infected by
ingestion of dead animals (mammals and birds
infected with WNV), and that subsequent high level
viremia was observed [35]. Therefore, combination of
persistent infection and predation may oﬀer a possi-
ble mechanism for WNV overwintering. Also, in case
of persistent infection and immune impairment of the
host, a recrudescence of the viremia may occur, oﬀer-
ing an alternative explanation for overwintering [36].
On the other hand, WNV persistence in overwintering
Table 2. Probability of WNV re-emergence in a given geogra-
phical unit (NUTS3 level or equivalent unit for non-EU coun-
tries) in a year, according to the number of human cases of
WNV reported in that geographical unit in the previous year.
Number of WNV
human cases in a
given region and
year
Number of times that
number of WNV human
cases in a given region
and year have been
detected
Probability of WNV re-
emergence in that
geographical unit in
the next year
>15 24 100%
10–15 11 73%
4–9 42 40%
<4 115 16%
Total 192 35%
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female mosquitoes in frost-free places has also been
demonstrated in Europe [37]; this is the most likely
way how the virus ‘survives’ the European winter.
In Russia, higher temperatures in May-June, and (to
a lesser extent) in August-September were associated
with an increase of human WND incidence [38].
Studies carried out in diﬀerent countries aﬀected by
WNV outbreaks (France, Italy, Serbia and Greece) evi-
denced a strong positive correlation between the
mean temperatures and the abundance of Cx. pipiens,
and therefore also the risk of WNV transmission [39].
Areas of WNV transmission in EE. Results from
oﬃcial reporting in horses, or seroprevalence stu-
dies carried out in birds and horses, evidence that
in some cases WNV transmission occurred in areas
where human cases were not reported. In fact,
while ECDC data includes both probable and con-
ﬁrmed cases, it should be taken into account that
the majority of people infected with WNV are
asymptomatic or show mild-nonspeciﬁc symptoms,
which are unlikely to be detected, and that may
result in the underestimation of the level of infec-
tion in the human population.
The data indicates that in EE large WNV human
epidemics occurred in highly populated urban areas
located such as Bucharest, Volgograd, Thessaloniki
and Belgrade. That resulted in hundreds of WNV
human cases in the last few years. In fact, the vast
majority of WNV human cases in Europe have
occurred in EE. The drivers of human epidemics, in
particular large epidemics, are not clear.
Usutu virus (USUV)
USUV was isolated for the ﬁrst time from Culex neavei
mosquitoes in South Africa in 1959 [40], and it has
dispersed through the African continent [41]. USUV
has been repeatedly introduced into Europe by migra-
tory birds over the last decades [42]. In Europe, USUV
was identiﬁed for the ﬁrst time in 2001 after a con-
siderable mortality of Eurasian blackbirds (Turdus mer-
ula) in Vienna, Austria [43]. However its introduction
could be traced back to at least 1996, when USUV was
identiﬁed retrospectively in a bird die-oﬀ event in
the Tuscany region (Italy) [44]. In subsequent years,
USUV was detected in neighbouring countries, includ-
ing Italy, Germany, Spain, Hungary, Switzerland,
Poland, England, Czech Republic, Belgium, Serbia
and Greece [45,46]. Clinical disease in humans asso-
ciated to USUV infections have been reported both in
Africa and Europe, with symptoms ranging from fever
and rash to meningoencephalitis [47]. Recently, USUV
was also detected in blood donations in Austria [48].
Of the EE countries included in the study, one serum
of domestic pigeon was positive for neutralizing anti-
bodies directed against USUV in Veria city (Central
Greece) in November 2010, suggesting the virus cir-
culation in that region, although the geographical
spread of USUV within Greece is still unknown [49].
In 2015, USUV speciﬁc IgG antibodies were detected
in 7 (out of 93) healthy persons subjected to routine
serological tests in the South Bačka district of north-
ern Serbia, conﬁrming the circulation of the virus in
the area [50]. USUV circulation both in Greece and in
Serbia occurred in areas and periods in which WNV
was also circulating. The eﬀect that coinfections of
diﬀerent arboviruses, in both the hosts and in the
vectors, may have, deserves further attention [19].
The recurrence of USUV in several European countries
suggest the establishment of an endemic cycle in
some of the aﬀected areas [46,51,52], possibly
through overwintering mosquitoes [53].
Dengue virus (DENV)
Dengue is the most widespread arboviral disease
aﬀecting humans, and it is caused by four dengue
virus serotypes (DENV 1–4) [54]. The historical origin
of DENV remains unclear. It is present mostly in the
tropics and subtropics, being endemic in more than
100 countries in south-eastern Asia, the Americas, the
western Paciﬁc, Africa and the eastern Mediterranean
regions [54]. Additionally, DENV is considered one of
the most important arboviruses because of the high
morbidity it causes: estimated in more than 390 mil-
lion cases per year [55]. The primary vectors of DENV
Figure 3. In dark red dates when reporting of new cases start for diﬀerent countries and years. In orange, period between ﬁrst
and last report for that country and year (proxy of the period of WNV transmission). Only the ﬁrst case in each area is available
in the ECDC tables, so the actual date of the last case may be later than reported in the ﬁgure.
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are Ae. aegypti and Ae. albopictus. The infection with
any of the DENV serotypes can be either asympto-
matic (in 75% of the cases), or result in one of the
three clinical forms with increasing severity: dengue
fever, dengue hemorrhagic fever, and dengue shock
syndrome.
A disease clinically compatible with dengue was
reported in Athens in 1928. This would have been
the last major dengue epidemic in Europe, with
roughly 1 million cases and 1000 deaths [56]. Since
then, no transmission of Dengue was reported in
Europe until 2010, when one autochthonous Dengue
case were recorded in Croatia [57] and two other
cases in France [58]. In 2012, after the identiﬁcation
of two autochthonous dengue fever cases, up to
1,891 cases were reported in the Portuguese island
of Madeira [59]. Since DENV usually produces asymp-
tomatic infection, it is possible that it may have been
circulating in other European countries with no clin-
ical manifestations. In fact, data from blood donors in
Turkey indicate exposure to DENV despite the lack of
reporting of clinical cases [60]. Considering the
increasing frequency of dengue epidemics worldwide
and the growing number of people travelling abroad,
the number of DENV-infected viraemic travellers arriv-
ing to EE is likely to increase in the near future. That,
and the presence of vectors competent for DENV
transmission (both Ae. aegypti and Ae. albopictus) in
large areas of south-eastern Europe, which are likely
to expand, indicate that autochthonous cases are
likely to occur in the area.
Orthobunyaviruses (genus Orthobunyavirus,
family Peribunyaviridae)
Bunyamwera orthobunyavirus (BUNV)
BUNV has also been known as Batai or Calovo virus in
EE. BUNV was ﬁrst isolated in 1943 from Aedes mos-
quitoes in Uganda [61]. In the 1970s, BUNV was
detected in An. maculipennis s.l. in Ukraine and
Moldova [7,8]. In humans, BUNV has been associated
with inﬂuenza-like illness accompanied by malaise,
myalgia, and anorexia [62,63]. Vertebrate hosts of
BUNV include pigs, horses and ruminants, but it has
also been isolated from diﬀerent species of birds.
BUNV is thought to be pathogenic for sheep and
goats, likely to cause stillbirths and congenital
abnormalities, and therefore may be relevant to moni-
tor it when those problems are detected in domestic
ruminants in Europe [8]. In the European area of
Russia, antibodies in humans and in bovine sera
have been found in the Saratov province [64,65] and
in the estuary of Kuban River [66]. Molecular analysis
of BUNV have demonstrated that the strains isolated
in Russia grouped into a European cluster together
with isolates from Ukraine and the Czech Republic,
and they were distinct to Asian and African
strains [67,68]. While serological data indicate that
BUNV is endemic in diﬀerent regions of EE [8], a
broader geographical distribution of BUNV remains
without conﬁrmation by virus isolation. Further
research on pathogenesis and transmission of BUNV
to animals and humans is necessary to better under-
standing its epidemiology.
California encephalitis orthobunyavirus (CEV)
CEV has also been historically known as Tahyna virus,
Snowshoe Hare virus and Inkoo virus in EE. CEV was
originally isolated from Aedes vexans and Aedes caspius
in Slovakia in 1958 [69]. Later it was also isolated from
mosquitoes in Moldova [7]. This was the ﬁrst mobovirus
pathogenic for humans isolated in Europe [8]. Human
disease caused by CEV, called ‘Valtice fever’ is an inﬂu-
enza-like illness aﬀecting mainly children. CEV has been
isolated from mosquitoes, humans and rodents in the
Central and southern territories of the Russian plain
situated in the southern taiga, mixed forest, broad-
leaved forest, forest-steppe, steppe and semiarid zones
[70]. Cases of CEV were documented in the 1980s and
1990s in the European area of Russia, Ukraine [71] and
Serbia and Montenegro [72]. The disease has a well
apparent seasonal pattern (July-August) [73]. The high-
est infection rate of mosquitoes was observed at the
end of the epidemic season in all regions [74]. Human
antibodies to CEV have been found in Rumania [75] and
in Saratov province (Russia) [64]. The vertebrate hosts of
CEV are lagomorphs (hares and rabbits), hedgehogs,
and rodents [8]. However, virus-neutralizing antibodies
to CEV have been found in gulls, terns and in bald-coots
in Russia [66] as well as in wild ungulates in Romania,
Hungary and Austria [76]. Animal disease caused by CEV
is unknown in EE.
Turlock orthobunyavirus (TURV)
TURV has also been known as Lednice virus in EE. Its
pathogenicity for humans and animals is still
unknown. Presence of antibodies to TURV was evalu-
ated in migratory birds of the Danube Delta
(Romania), and from humans and domestic birds of
three Romanian counties [77]. Antibodies were
detected only in migratory birds, especially in wild
geese and ducks, but because these migrate, a geo-
graphic source of transmission remains unknown [77].
Regarding vectors, Culex modestus was implicated in
TURV transmission in Slovakia [78]. More information
on TURV biology would be needed to determine its
potential impact in animals and humans.
Phleboviruses (genus Phlebovirus, family
Phenuiviridae)
Rift valley fever phlebovirus (RVFV)
RVFV was described for the ﬁrst time in 1931 in
Kenya [79]. Since then, RVFV caused large animal
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and human epidemics in several African coun-
tries [80]. RVFV infection of animals may occur by
the bite of an infected mosquito (mainly of the Culex
or Aedes genera), or through direct contact with
infected animal tissues or ﬂuids [81]. The pathogen-
esis of the disease varies depending on breed, spe-
cies and age. Newborn lambs, goats and calfs
frequently develop an acute/hyperacute form of the
disease with high mortalities (up to 100%) [82]. Older
sheep, goats and cattle are more resistant to clinical
disease, but can exhibit high fever, anorexia, depres-
sion, lymphadenitis, vomiting, weakness, nasal and
ocular discharges, diarrhoea, abortions at any stage
of pregnancy, and necrotic hepatitis (mortality rates
10–30%). Camels and wild ruminants usually develop
subclinical infections; however, the disease can lead
to sudden mortality and abortions [82,83]. In
humans, the disease causes a ﬂu-like syndrome in
most infected individuals, but can also cause severe
encephalitic or haemorrhagic forms and even
death [84]. In 2000, RVFV was ﬁrst reported outside
Africa, in Saudi Arabia and Yemen [85]. Serological
evidence for RVFV infection was also detected in
Turkey: one out of 71 camel samples and 35 out of
410 buﬀalo samples from 2000 and 2001 were posi-
tive for RVFV-speciﬁc antibodies [86]. It was sug-
gested that RVF infection was introduced into
Turkey at the time of outbreaks in Saudi Arabia and
Yemen through uncontrolled movement of viraemic
domestic or wild animals or vectors, through the
southern border with Syria and Iraq. No clinical or
suspected RVF cases were reported in humans or
animals in Turkey, but RVFV can circulate with mild
or even no clinical signs, remaining undetected in an
area, and emerge when eco-climatic conditions are
favourable for transmission [87]. EE is at risk of RVF
because of both the presence of competent vectors
and the climatic conditions in the area, which are
favourable for RVFV transmission [88].
Alphaviruses (genus Alphavirus, family
Togaviridae)
Sindbis virus (SINV)
SINV was ﬁrst isolated in 1952 from Cx. pipiens and Cx.
univittatus mosquitoes captured in the Sindbis Health
District, north of Cairo [89]. SINV has a worldwide
distribution including Eurasia, Africa, and Oceania. It
is transmitted among its natural bird hosts, mainly
Passeriformes, via mosquitoes. In birds, the virus can
cause sporadic illness (pigeon-encephalitis) and irre-
gular deaths in old chickens [8]. SINV is thought to
have entered Europe from Africa through Israel,
reﬂecting migratory bird pathways [6]. First
European SINV isolation was reported from a reed
warbler caught in Slovakia in 1971 [90]. Human dis-
ease caused by SINV infection has been reported
mainly in South Africa and in Northern Europe. The
disease has diﬀerent names depending on the region
aﬀected. In north-western Russia, it was known as
‘Karelian’ fever [91]. Symptoms include fever, malaise,
rash and musculoskeletal pain. In a signiﬁcant portion
of patients, the debilitating musculoskeletal symp-
toms persist for years [92]. Silent circulation in more
recent years should not be discarded since most
symptoms of SINV infection are compatible with
other human infectious diseases. Antibodies to SINV
were detected in Saratov province (Russia) in the end-
1990s [60]. The most recent report of SINV circulation
in EE was from the Kuvan River, in the north-west
Caucasus region of Russia in 2006–2007. In this wet-
land, virus-neutralizing antibodies to SINV were found
in European hares and in herons [66].
Ecological/biological aspects of the mosquito
vectors of arboviruses in EE
The capacity of a pathogen to transmit within a popu-
lation is frequently measured by the basic reproduc-
tion number (R0), deﬁned as the number of secondary
cases which one case would produce in a completely
susceptible population. R0 varies considerably for dif-
ferent infectious diseases but also for the same dis-
ease in diﬀerent populations [93]. For vector-borne
diseases, R0 is typically estimated according to the
Ross-MacDonald formula [94], which takes into
account: the ratio of mosquitoes to hosts, the rate at
which mosquitoes bite the hosts, the daily probability
of survival for mosquitoes, the vector competence,
the extrinsic incubation period, the host infectious-
ness, and the host’ recovery rate. Therefore, in order
to estimate the risk of transmission posed by a mobo-
virus, it is essential to understand all the biological
and ecological factors that drive viral transmission,
and which include the following factors related to
the vectors: (i) abundance and dynamics during
the season; (ii) biting behaviour; (iii) dispersal capacity;
(iv) vector competence; (v) availability and type of
larval breeding sites. Knowledge of those parameters
is also crucial for eﬃcient vector control. In the pre-
sent manuscript, we highlight the main biological and
ecological aspects of the mosquito species present in
EE, to better estimate the risk of mosquito-borne
transmission in the region.
Nine mosquito species: Culex (Culex) pipiens, Culex
(Barraudius) modestus, Culex (Culex) perexiguus, Culex
(Culex) quinquefasciatus, Aedes (Aedimorphus) vexans,
Aedes (Ochlerotatus) caspius, Aedes (Stegomyia) albo-
pictus, Aedes (Stegomyia) cretinus, Aedes (Stegomyia)
aegypti were considered as the main mosquito spe-
cies (on the basis of their proven or potential role as
vectors of moboviruses in EE), and their distribution is
shown in Table 3.
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Culex (culex) pipiens linnaeus 1758
Culex pipiens is widespread in the Holarctic region,
and it is found in all 13 countries of EE included in
the study (Table 3). This species comprises two mor-
phologically identical biotypes, pipiens and molestus,
as well as their hybrids. No comprehensive data of the
occurrence of biotypes pipiens, molestus and their
hybrids throughout EE region is available. The two
biotypes and the hybrid form of Cx. pipiens are all
morphologically similar to Cx. torrentium with whom
are sympatric in much of Central, Eastern and
Northern Europe [95]. Cx. pipiens larvae can inhabit
nearly every kind of water collection, artiﬁcial and
natural, even tolerating a small amount of salinity.
This species can develop up to several generations
per year depending on climatic conditions.
From the data obtained in European countries,
Cx. pipiens is the mosquito species most commonly
associated with both WNV [96] and USUV [97–99].
Culex pipiens biotype pipiens linnaeus 1758
Culex pipiens biotype pipiens is strongly avian-seeking
(ornithophilic) and therefore plays a major role in
both WNV and USUV transmission [100].
Females overwinter in diapause. In the spring,
when average daily temperature rises above 10°C,
females search for blood and lay their eggs on the
water surface glued in an egg raft of 150–240 eggs.
The larvae hatch within one or two days and com-
plete their development to adults in between one
week and one month depending on the
temperature.
Culex pipiens biotype molestus forskal 1775
The biotype molestus occurs more frequently in
human settlements. The most common larval habi-
tats are road drains, ﬂooded basements, under-
ground sewage constructions, and other human-
made water containers. The biotype molestus is
mammalophilic and bites humans both indoors
and outdoors, after sunset and during the night.
As it is autogenous, it may lay eggs without a
blood meal, although much fewer (10–50 per egg
raft) when it feeds on blood. It can reproduce
throughout the winter in warm urban habitats con-
taining water, or may overwinter in human-made
shelters. There are records of biotype molestus
even from very northern cities in the European
parts of Russia.
Hybrids between the two biotypes have an inter-
mediate host preference and are therefore ideal
bridge vectors of WNV and USUV from birds to mam-
mals [100]. In terms of vector competence, European
Cx. pipiens hybrid forms have been shown to be able
to transmit WNV [101] and RVFV [102].
Culex (barraudius) modestus ﬁcalbi 1889
Culex modestus has been reported in 12 out of 13 EE
countries (Table 3). However, its distribution through-
out the EE region is patchy and usually limited to
fresh or slightly saline waters of marshes, irrigation
canals and inundation areas of rivers and rice ﬁelds.
Dispersal ability of Cx. modestus is very low, so the
aggressive females remain localized around larval
breeding sites [103], which diminishes its importance
in the transmission of moboviruses to humans in
semi-urban and urban surroundings. However, it
could serve as important enzootic and a bridge vector
in natural/rural wetland environments across EE.
The seasonal maximum of the adult population
might occur from the beginning of July to late
September depending on weather conditions. The
females readily bite humans outdoors, close to
the breeding sites, often during the day, even at sun
and in wind-exposed places [104]. Balenghien and
collaborators [105] regarded Cx. modestus as the pri-
mary vector of WNV in wetland areas of southern
France after demonstrating high dissemination and
transmission rates of the virus in the laboratory, and
considering its biting behaviour (ornithophilic and
mammalophilic). Apart from WNV, this species has
been implicated as a vector of CEV and TURV [78].
Culex (culex) perexiguus theobald 1903
Culex perixiguus species has been found in 5 out of 13
EE countries (Table 3). The larvae can be found in many
kinds of stagnant water collections, from clean to mod-
erately polluted swamps, ponds, streams, pools, wells,
usually with emergent vegetation, and occasionally in
human-made containers. The species is common dur-
ing summer and autumn in natural/rural habitats.
Cx. perexiguus has been implicated in WNV circula-
tion since they feed mainly on birds, although it may
also be implicated in WNV transmission to horses,
since horse blood has also been identiﬁed in this
species [106]. On the other hand, Gad and collabora-
tors [107] indicated that Cx. perexiguus may have
served as a bridge vector of RVFV between bovines
and humans in Egypt, since mixed blood meals from
humans and RVFV susceptible animals were identiﬁed
in Cx. perexiguus.
Culex (culex) quinquefasciatus say 1823
Culex quinquefasciatus, the southern house mosquito,
is one of the most troublesome mosquitoes in the
world, and it is widespread throughout the tropics
and subtropics [104]. Of the countries included in
the study, it has only been recorded in Turkey
(Table 3). In 2015, Gunay and collaborators [108]
recorded the wide geographical distribution of Cx.
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quinquefasciatus across most of southern Turkey,
while hybrids between this species and Cx. pipiens
had been detected in the Greek island of Kos, close
to the Turkish coast in 2012 [109].
The larvae breed in any artiﬁcial and natural water
collection, ranging from fresh and clear to saline and
polluted. The females are ferocious and bite humans
at night, both indoors and outdoors. They also fre-
quently attack birds and, to a lesser extent, domestic
animals, such as dogs, cats, and pigs. The range of
hosts varies depending on the characteristics of the
local population. The females develop throughout the
whole year [110].
Cx. quinquefasciatus is incriminated as primary vector
of WNV [111], and therefore the expansion of Cx. quin-
quefasciatus and its hybrids north and west of current
distribution represents a new threat to EE countries.
Aedes (aedimorphus) vexans (meigen 1830)
Aedes vexans is a native species widely distributed
through EE (present in all 13 countries, see Table 3).
They may have several generations per year depend-
ing on the number of water ﬂuctuations, and when
the temperature of the water in the breeding sites
exceeds 9°C [104]. The preferred breeding sites are
ﬂoodplains of rivers and lakes holding temporary
water bodies. The females lay the eggs 5–8 days
after the blood meal into the ground that is subjected
to ﬂooding. In temperate climates, egg diapause lasts
from September to March. Frost toleration of eggs is
extraordinary; they can survive several days with tem-
peratures below −10°C. The hatching rate is particu-
larly elevated at high water temperatures. If there are
no water ﬂuctuations above the level where the eggs
were laid during following season, the eggs can sur-
vive for a long time (more than ﬁve years). Ae. vexans
frequently emerges en masse during the summer
months depending on the water ﬂuctuations, and is
often the most critical nuisance mosquito around
rivers and lakes. The females usually disperse long
distances from their breeding sites (10–30 km).
Ae. vexans are mainly mammalophilic and have been
involved in the transmission of CEV [112]. Even though
it has been found naturally infected with WNV in Serbia
[113], its role in WNV transmission is not clear. In the
north-eastern United States Ae. vexans was described as
a vector of minor importance for WNV transmission
[111]. However, in the laboratory assays, WNV vector
competence of Ae. vexans was similar to that of Cx.
pipiens. In addition, CEV was isolated from Ae. vexans
in South Moravia (Czech Republic) [114], and Ae. vexans
was implicated in RVFV epidemiology in Senegal and
Saudi Arabia [115]. Recently, O’Donnell and collabora-
tors [116] found that Ae. vexans was able to transmit
ZIKV, which together with its abundance and capacity
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for multiple feeding on humans, may result in a high
vectorial capacity for ZIKV.
Aedes (ochlerotatus) caspius (pallas 1771)
Aedes caspius is a native species and widely distributed
through EE (present in all 13 countries, see Table 3). Ae.
caspius may develop several generations per year
depending on the characteristics of the breeding site
but sometimes only one generation per year is pro-
duced. Similar to Ae. vexans, the species overwinters in
the egg stage. Eggs hatch after submersion with water
due to the ﬂuctuation of the water level in a breeding
site. The hatching time in spring varies with the latitude,
and occurs in March in most of the countries of EE. The
larvae develop in freshwater bodies, but also in saline
water common in Mediterranean coastal marshes [104].
The females feed on humans and animals both in rural
and urban areas. They are crepuscular feeders, most
actively searching for a blood meal at dusk, but may
bite during the day and night. They normally feed out-
doors, but may feed in houses and animal shelters when
abundant. Females hunt for blood at temperatures ran-
ging from 11.5 to 36°C and relative humidity from 47 to
92%, and may disperse up to 10 km [117,118].
Both WNV and CEV were detected in natural popula-
tions of Ae. caspius in Russia [119]. Ae. caspiuswas found
to be an ineﬃcient vector of WNV in the laboratory and,
despite its high densities, was assigned a minor role in
WNV transmission in southern France [105]. Gad and
collaborators [107] indicated that Ae. caspius may have
served as a bridge vector of RVFV between bovines and
humans in Egypt. However, it was found to bemuch less
eﬃcient in the dissemination of RVFV in laboratory con-
ditions than Cx. pipiens [120].
Aedes (stegomyia) albopictus (skuse1895)
Aedes albopictus is native to south-east Asia and
Oceania, therefore its popular name, the ‘Asian tiger
mosquito’. Its worldwide spread is considered to have
started in Albania where it was introduced in 1979, or
even before [121]. In 1985, it was discovered in Houston,
Texas (the ﬁrst in America), which was the beginning of
its rapid spread to other parts of the world [122]. Since
1999 Ae. albopictus has been introduced and estab-
lished in 30 European countries according to ECDC,
including nine of the 13 countries included in our
study (Table 3). Local climatic conditions combined
with passive dispersal mechanisms are likely to result
in further expansion of Ae. albopictus to naive EE coun-
tries [113,123]. Even though they are weak ﬂyers, Ae.
albopictus can spread rapidly within countries through
passive mechanisms [124]. In Europe, this species is
conﬁned to human settlements, and the immature
stages breed in a variety of small natural and artiﬁcial
containers. In temperate climatic zones of EE,
populations of Ae. albopictus overwinter in the cold-
resistant egg stage. The eggs are also resistant to desic-
cation, which facilitates their transport around the
world. Adult females predominantly feed on humans,
but may also bite other mammals and occasionally birds
[104]. Such feeding behaviour makes Ae. albopictus an
excellent vector of a variety of arboviruses that use
mammals and birds as their reservoir hosts [122]. The
females bite man during the daytime, outdoors in urban
and semi-urban environments, but may also feed inside
houses during the day and night.
Ae. albopictus is a competent vector to 26 arboviruses
in laboratory conditions [125] including WNV [101] and
RVFV [102]. It has also been found infected with USUV in
the ﬁeld [126]. Ae. albopictus was in 2007, the ﬁrst
invasive mosquito species involved in transmitting an
exotic virus in Europe (CHIKV in Italy [127]. Later on, Ae.
albopictus was also implicated in the transmission of
CHIKV in France in 2010 [128] and 2014 [129], and also
DENV in Croatia in 2010 [57] and in France in 2010 [58],
2013 [130] and 2015 [131].
Aedes (stegomyia) cretinus edwards 1921
Aedes cretinus has been recorded in 3 out of 13 EE
countries, although the record of Russia dates from
1931 (Table 3). Abundant populations have been
reported in Athens (Greece) [132] and Antalya
(Turkey) [133]. Elsewhere it seems to be an uncommon
species, although its distribution range could also be
underestimated by the preference of Ae. cretinus for
rural habitats and to the lack of knowledge on its bio-
ecology [134]. No vector competence studies have
been carried out on Ae. cretinus, so its vectorial capacity
for the diﬀerent moboviruses is still unknown [135].
Aedes (stegomyia) aegypti (linnaeus 1762)
In Europe, before 1945, all Mediterranean countries and
most major port cities had reported at least occasional
introductions of Ae. aegypti [122]. It seems that it was
eliminated from Europe thanks to the sanitation of
urban water collections and the anti-malaria campaigns
with DDT during the 1950s. Since then, diﬀerent coun-
tries in EE (e.g. Albania, Greece and Turkey) have spor-
adically reported Ae. aegypti, although without
evidence of established populations [135]. It was not
considered established in EE until 2007 when it was
found in the Black Sea coast of Russia and in Georgia
[124,136]. In 2015, Ae. aegypti was detected in north-
eastern Turkey [137], and since then has spread west-
wards along the Black Sea coast of Turkey (Akiner,
personal communication). Currently it is recorded in
two out of 13 EE countries studied, Turkey and Russia
(Table 3). Its range of distribution is apparently limited
by the 10°C January isotherm in the northern hemi-
sphere, although several records from Europe (Brest,
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Odessa) corresponded to much lower temperatures
[138]. It is intriguing that the areas of its reestablish-
ment in Russia, Georgia and north-eastern Turkey are
zones with lower January temperatures. If the popula-
tion introduced in Russia is adapted to colder tempera-
ture conditions, then much broader areas of Europe
would be at risk of invasion by Ae. aegypti.
In Europe, this species is conﬁned to human settle-
ments. The female lays eggs resistant to desiccation in
artiﬁcial human-made containers and water recipients
of all kinds, both in- and outdoors. Eggs, larvae and
adults are not able to overwinter under conditions of
temperate climate, but might use warm, protected
sites in urban environments (cellars of human houses)
that can provide shelters, blood sources and oviposi-
tion sites. They might travel west across the Black Sea
in artiﬁcial water collection sites on ships. The larvae
spend a long time underwater feeding on the bottom
of their breeding sites, which may make their detec-
tion diﬃcult for untrained personnel. At a tempera-
ture of 27 to 30°C the adults emerge from the pupae
9–10 days after the eggs have been laid. The females
feed predominantly during the day, outdoors in
shaded places but can also feed and rest indoors.
Human blood seems to be preferred to that of domes-
tic animals, and the females prefer to take multiple
blood meals (feeding on more than one person for
obtaining full blood meal); and the blood feeding
interval is only about 2–4 days [94,124]. Its feeding
behaviour makes Ae. aegypti an excellent vector of
human arboviruses. Females do not ﬂy over long dis-
tances, often not more than several hundred meters
away from breeding sites.
Aedes aegypti is the principal vector of yellow fever
virus (‘yellow fever mosquito’), but it is also an important
vector ofDENV, CHIKV andZIKV,which threaten the EE [6].
Conclusions
The epidemiology of WNV in EE is rather complex
with the combination of the repeated introduction
of WNV strains from both lineages 1 and 2, but also
the establishment of endemic cycles. In many cases
those WNV strains overwinter in aﬀected areas and re-
emerge in the following season in the same areas
after a period that lasts many months, and in some
occasions, they expand to neighboring regions. The
risk of WNV re-emergence in a given area increases
proportionally to the number of human cases in the
previous year, which was probably related to the level
of viral circulation. This complex scenario resulted in
2873 human cases in the EE countries included in the
study between 2010 and 2016.
Other moboviruses reviewed such as BUNV, CEV,
TURV, SINV, and even USUV, are considered to be
established in EE. However, many aspects of their
epidemiology including their current distribution,
their vectors and hosts, or their pathogenicity for
animals and humans are not clear. The overlapping
of diﬀerent arboviruses in EE is likely to result in
coinfections, in both the hosts and in the vectors,
the eﬀect of which are unknown.
The case of DENV is a bit diﬀerent, as it is
considered exotic to EE, although some autochtho-
nous cases have been reported in other areas of
Europe. However, the risk of epidemics in EE is
likely to increase in near future as a result of: a)
the proliferation of DENV epidemics worldwide,
with an increase in the number of DENV-infected
viraemic travelers arriving to EE, and b) to pre-
sence of vectors competent for DENV transmission
(Ae. aegypti and Ae. albopictus) in large areas of
south-eastern Europe. Whether that may result in
the establishment of an endemic cycle remains to
be seen.
RVFV also has a known zoonotic potential and it
has traditionally been considered exotic to EE.
However, some serological evidence for RVFV infec-
tion in Turkey in 2017, and both the presence of
competent vectors and the favourable climatic condi-
tions for RVFV transmission in EE, evidence the need
to remain vigilant.
Reported distribution of moboviruses in EE is likely
to be biased by the diﬀerences in the intensity of
surveillance among countries, which is highly inﬂu-
enced by the resources available. For example, in
Belarus no circulation of moboviruses has been
reported, and in countries such as Kosovo,
Macedonia, Albania and Bulgaria, only WNV has
been detected.
While the competence of some mosquito species
for the transmission of some moboviruses has been
clearly demonstrated (for example Culex (Culex)
pipiens for WNV transmission), there are many knowl-
edge gaps in relation to the role of several mosquito
species present in EE for the transmission of the
moboviruses present in the area.
Current expansion of invasive mosquito species,
mainly Ae. albopictus but also Ae. aegypti, in EE, very
eﬃcient vectors of human moboviruses such as DENV,
CHIKV and ZIKV may result in new scenarios for the
emergence of those diseases in EE. Additionally,
recent detection in Turkey and Greece of Cx. quinque-
fasciatus or its hybrids, represents a cause for concern,
as this species is one of the most troublesome mos-
quitoes in tropical and subtropical areas of the world,
and it is a primary vector of WNV.
As a result of the current increasing trend in
many anthropogenic factors such as human popula-
tion, deforestation, urbanization and movements of
people, animals and vectors, as well as, to some
extent, the eﬀect of climate change, further spread
of moboviruses in EE is to be expected in the
future.
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